Related Experiment Video

Updated: May 10, 2026

Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study
08:40

Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study

Published on: November 11, 2022

Systematic review and evidence-based clinical recommendations for dosing of pediatric supported standing programs

Ginny S Paleg1, Beth A Smith, Leslie B Glickman

  • 1Montgomery County Infants and Toddlers Program , Rockville, Maryland, USA. ginny@paleg.com

Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association
|June 26, 2013
PubMed

Insights

Supported standing programs for children can improve bone density, hip stability, range of motion, and spasticity when implemented 5 days weekly. Specific durations are recommended for each therapeutic goal.

Area of Science:

  • Pediatric Physical Therapy
  • Rehabilitation Medicine
  • Biomedical Engineering

Background:

  • Supported standing programs are widely used in pediatric care.
  • Evidence-based dosing guidelines for these programs are lacking.
  • This study addresses the need for effective pediatric standing program recommendations.

Purpose of the Study:

  • To establish evidence-based dosing recommendations for pediatric supported standing programs.
  • To synthesize current evidence on the benefits of supported standing.
  • To guide clinical decision-making for pediatric physical therapy interventions.

Main Methods:

  • Systematic literature search across 7 databases using the International Classification of Functioning, Disability, and Health (Child and Youth Version) framework.
  • Inclusion criteria applied to identify relevant studies.
  • Evidence strength evaluated using established tools.

Main Results:

  • 30 out of 687 studies met the inclusion criteria.
  • Positive effects on bone mineral density (60-90 min/d, 5 days/week).
  • Improvements in hip stability (60 min/d, 30°-60° abduction).
  • Enhanced range of motion in hip, knee, and ankle (45-60 min/d, 5 days/week).
  • Reduced spasticity (30-45 min/d, 5 days/week).

Conclusions:

  • Evidence supports specific dosing for pediatric supported standing programs.
  • 5 days/week of standing positively impacts bone density, hip stability, range of motion, and spasticity.
  • Recommendations provided to aid clinical practice and decision-making.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...